Atropine to control myopia after cataract surgery in children
Part of Blood & lymphatic, Cancer, Eyes & vision, Immune system & allergy clinical trials.
This trial tests if atropine 0.05% eye drops can slow down nearsightedness in children who have had cataract surgery and a lens implant. It is for children ages 1 to 7.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had cataract surgery and received an artificial lens implant
- Your child must be between 1 and 7 years old
- The operated eye must be clear enough for the doctor to check vision
- There should be no other serious eye problems like glaucoma, retinal disease, or birth defects
- The surgery must have been straightforward, without complications like retinal detachment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This study tests if using atropine eye drops in increasing doses can prevent nearsightedness (myopia) in children who are at risk. It is for children aged 6 to 9 who do not yet need glasses but have early signs of developing myopia.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Hear when a new Pediatric Cataract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.